XENON Trademark

Trademark Overview

On Tuesday, May 21, 2024, a trademark application was filed for XENON with the United States Patent and Trademark Office. The USPTO has given the XENON trademark a serial number of 98560961. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Thursday, May 7, 2026. This trademark is owned by XENON PHARMACEUTICALS INC.. The XENON trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing healthcare providers and patients information regarding neurological disease states and treatment

General Information

Serial Number98560961
Word MarkXENON
Filing DateTuesday, May 21, 2024
Status680 - APPROVED FOR PUBLICATION
Status DateThursday, May 7, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesProviding healthcare providers and patients information regarding neurological disease states and treatment

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 21, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameXENON PHARMACEUTICALS INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBurnaby V5G4W8
CA

Trademark Events

Event DateEvent Description
Tuesday, May 21, 2024NEW APPLICATION ENTERED
Tuesday, May 21, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 19, 2024ASSIGNED TO EXAMINER
Tuesday, November 26, 2024NON-FINAL ACTION WRITTEN
Tuesday, November 26, 2024NON-FINAL ACTION E-MAILED
Tuesday, November 26, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 3, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 3, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 3, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 3, 2025NON-FINAL ACTION WRITTEN
Monday, March 3, 2025NON-FINAL ACTION E-MAILED
Monday, March 3, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 3, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, June 3, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, August 5, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 5, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 5, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 5, 2025FINAL REFUSAL WRITTEN
Friday, September 5, 2025FINAL REFUSAL E-MAILED
Friday, September 5, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, December 1, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, December 1, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, December 9, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 9, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 9, 2025TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Tuesday, December 9, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 9, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, January 7, 2026TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, January 7, 2026APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, January 7, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 7, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 7, 2026TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, January 7, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 5, 2026EXPARTE APPEAL RECEIVED AT TTAB
Thursday, March 5, 2026JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, March 5, 2026EX PARTE APPEAL-INSTITUTED
Thursday, March 5, 2026TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, March 5, 2026TEAS REQUEST TO DIVIDE RECEIVED
Thursday, March 12, 2026ASSIGNED TO LIE
Thursday, March 12, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 5, 2026DIVISIONAL REQUEST RECEIVED
Wednesday, May 6, 2026DIVISIONAL PROCESSING COMPLETE
Thursday, May 7, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 7, 2026EXPARTE APPEAL TERMINATED

Related Keywords

xenon neurological disease states treatment regarding information healthcare providers patients providing